Tirzepatide weight loss, the generic version of Mounjaro, is an FDA-approved antidiabetic medication used for treating type 2 diabetes and has shown promising results in studies to help with weight loss even for people without diabetes
1c,d) which catabolize 25(OH)VD 3 and active 1,25(OH) 2 D 3
20 : 19 Taglialatela G, Navarra D, Cruciani R, Ramacci MT, Alema GS, Angelucci L
The 40:1 myo-inositol/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios
While it has been shown to help many people with blood sugar control and weight loss, questions have been raised about whether it might trigger or worsen autoimmune conditions in some patients